Notice2023-28371
National Cancer Institute; Cancellation of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 26, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 246 (Tuesday, December 26, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)]
[Notices]
[Page 88930]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-28371]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Cancellation of Meeting
Notice is hereby given of the cancellation of the National Cancer
Institute Special Emphasis Panel, SEP-11: NCI Clinical and
Translational Cancer Research, March 7, 2024, 10:00 a.m. to March 7,
2024, 1:30 p.m., National Cancer Institute Shady Grove, Resources and
Training Review Branch, Division of Extramural Activities, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland, 20850 which was
published in the Federal Register on December 20, 2023, FR Doc. 2023-
27963, 88 FR 88100.
This meeting is being cancelled and will be rescheduled with a new
contact person.
Dated: December 20, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28371 Filed 12-22-23; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on December 26, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.